Announced Fri, 17 Apr · 10:25 IST

RTA Compliance certificate for Quarter ended March 31, 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+15.6%1-day move

₹30.93

prior close

₹29.50

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+0.0+15.6-1.4+6.2+1.8+3.4+0.2+5.9+0.2+115.6+226.3

Up moveDown movePending

AI summary

Parmax Pharma Ltd has filed a compliance certificate under SEBI Regulation 74(5) for Q4 FY26 (January-March 2026). The certificate confirms that 2 share certificates representing 200 shares held by shareholder Ketan R Jani were dematerialized on January 23, 2026. The RTA, Purva Sharegistry (India) Pvt. Ltd., has certified that the physical share certificates were properly mutilated and cancelled after verification, and the depository has been substituted as the registered owner within prescribed timelines. The filing confirms these dematerialized securities are listed on the relevant stock exchange. The certificate is signed by Managing Director Umang Gosalia and dated April 17, 2026.

Likely market impact

This is a routine regulatory compliance filing with no direct impact on shareholders or stock price. It confirms the company follows proper dematerialization procedures as mandated by SEBI regulations.